The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4
Open accessAbstract
// Peter Johansson 1 , Lauren G. Aoude 1 , Karin Wadt 2 , William J. Glasson 3 , Sunil K. Warrier 3 , Alex W. Hewitt 4, 5 , Jens Folke Kiilgaard 6 , Steffen Heegaard 6, 7 , Tim Isaacs 5 , Maria Franchina 5 , Christian Ingvar 8 , Tersia Vermeulen 9 , Kevin J. Whitehead 10 , Christopher W. Schmidt 1 , Jane M. Palmer 1 , Judith Symmons 1 , Anne-Marie Gerdes 2 , Göran Jönsson 8 , Nicholas K. Hayward 1 1 QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia 2 Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark 3 The Terrace Eye Centre, Brisbane, QLD, Australia 4 Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia 5 Lions Eye Institute, University of Western Australia, Perth, WA, Australia 6 Department of Ophthalmology, Rigshospitalet-Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark 7 Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark 8 Department of Clinical Sciences, Lund University, Lund, Sweden 9 The Royal Perth Hospital, Perth, WA, Australia 10 Sullivan Nicolaides Pathology, Brisbane, QLD, Australia Correspondence to: Peter Johansson, e-mail: Peter.Johansson@qimrberghofer.edu.au Keywords: uveal melanoma, recurrent mutation, PLCB4, copy number variation, structural variants Received: September 14, 2015 Accepted: November 26, 2015 Published: December 14, 2015 ABSTRACT Next generation sequencing of uveal melanoma (UM) samples has identified a number of recurrent oncogenic or loss-of-function mutations in key driver genes including: GNAQ , GNA11 , EIF1AX , SF3B1 and BAP1 . To search for additional driver mutations in this tumor type we carried out whole-genome or whole-exome sequencing of 28 tumors or primary cell lines. These samples have a low mutation burden, with a mean of 10.6 protein changing mutations per sample (range 0 to 53). As expected for these sun-shielded melanomas the mutation spectrum was not consistent with an ultraviolet radiation signature, instead, a BRCA mutation signature predominated. In addition to mutations in the known UM driver genes, we found a recurrent mutation in PLCB4 (c.G1888T, p.D630Y, NM_000933), which was validated using Sanger sequencing. The identical mutation was also found in published UM sequence data (1 of 56 tumors), supporting its role as a novel driver mutation in UM. PLCB4 p.D630Y mutations are mutually exclusive with mutations in GNA11 and GNAQ , consistent with PLCB4 being the canonical downstream target of the former gene products. Taken together these data suggest that the PLCB4 hotspot mutation is similarly a gain-of-function mutation leading to activation of the same signaling pathway, promoting UM tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
Self-citationA landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Cited by
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
Robertson, A. G., Shih, J., Yau, C., Gibb, E. A., Oba, J., Mungall, K. L., Hess, J. M., Uzunangelov, V., Walter, V., Danilova, L., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.003 · Cited by 887
Jager, M. J., Shields, C. L., Cebulla, C. M., Abdel-Rahman, M. H., Grossniklaus, H. E., Stern, M.-H., Carvajal, R. D., Belfort, R. N., Jia, R., Shields, J. A., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0158-0 · Cited by 825
Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor
Islam, S. M. A., Díaz-Gay, M., Wu, Y., Barnes, M., Vangara, R., Bergstrom, E. N., He, Y., Vella, M., Wang, J., Teague, J. W., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100179 · Cited by 365
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma
Moore, A. R., Ceraudo, E., Sher, J. J., Guan, Y., Shoushtari, A. N., Chang, M. T., Zhang, J. Q., Walczak, E. G., Kazmi, M. A., Taylor, B. S., et al. (2016) · Nature Genetics · doi:10.1038/ng.3549 · Cited by 314
Treatment of uveal melanoma: where are we now?
Yang, J., Manson, D. K., Marr, B. P., & Carvajal, R. D. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834018757175 · Cited by 300
Metadata
- Authors
- Johansson, P., Aoude, L. G., Wadt, K., Glasson, W. J., Warrier, S. K., Hewitt, A. W., Kiilgaard, J. F., Heegaard, S., Isaacs, T., Franchina, M., Ingvar, C., Vermeulen, T., Whitehead, K. J., Schmidt, C. W., Palmer, J. M., Symmons, J., Gerdes, A.-M., Jönsson, G., & Hayward, N. K.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-12-14
- Volume
- 7
- Issue
- 4
- Pages
- 4624-4631
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2280440990
- Cited by
- 303
- References
- 2
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4. https://app.cochat.ai/papers/10.18632/oncotarget.6614
- The paper
- Johansson, P., Aoude, L. G., Wadt, K., Glasson, W. J., Warrier, S. K., Hewitt, A. W., Kiilgaard, J. F., Heegaard, S., Isaacs, T., Franchina, M., Ingvar, C., Vermeulen, T., Whitehead, K. J., Schmidt, C. W., Palmer, J. M., Symmons, J., Gerdes, A.-M., Jönsson, G., & Hayward, N. K. (2016). Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4. Oncotarget. https://doi.org/10.18632/oncotarget.6614
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.